Skip to content

Quadratus Lumborum Block for Pediatric Hip Surgery

Caudal Epidural Block Compared to Anterior Quadratus Lumborum Block for Pediatric Hip Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04292782
Enrollment
40
Registered
2020-03-03
Start date
2020-03-31
Completion date
2021-12-31
Last updated
2024-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Dislocation, Congenital, Postoperative Pain, Anesthesia

Keywords

hip dislocation, regional anesthesia, surgery

Brief summary

Caudal blockade (CB) is one of the most frequently performed regional anaesthetic techniques in children. It's an efficient way to offer perioperative analgesia for painful sub-umbilical interventions but with high incidence of motor block and urinary retention. In one study, psoas compartment block was associated with less morphine comsumption and prolonged duration of analgesia compared to single-shot caudal Block in small children undergoing open hip reduction/osteotomies. Ultasound guided anterior Quadratus lumborum block (AQLB) provides unilateral analgesia to the nerves between the psoas muscle (PM) and the quadratus lumborum muscle (QLM). The first pediatric study evaluating Quadratus lumborum block is encouraging . The first pediatric study evaluating Quadratus lumborum block is encouraging. To the best of the investigator's knowledge, there are no previously published data comparing the AQLB with other regional techniques in infants undergoing hip surgery.

Detailed description

The aim of this prospective randomized study was to compare the analgesic effects between AQLB and CB in children undergoing unilateral open hip reduction/osteotomies for hip dislocation. Patients were randomly assigned, into 1 of 2 groups, namely, group CB (n = 20) and group AQLB (n = 20). Preoperatively all children were premedicated by using oral midazolam (0 .5mg/kg). anesthesia was induced with 3 to 4% sevoflurane and 50% with 60% nitrous oxide in oxygen.Then fentanyl 3 μg/kg and Propofol 1 - 2mg/Kg were administered for anesthesia induction. Airway was secured with endotracheal tube placed in the mouth facilited by 0.15 mg/kg cistracurium. Anesthesia maintenance was performed with sevoflurane 2% in 50% nitrous oxide. AQLB and CB were done with 1 ml/kg, 0.25% Ropivacaine (maximum dose limited to 20 ml) Postoperative follow-up: All patients received 15 mg/kg paracetamol before extubation. Tramadol 2 mg/kg intravenous was planned as rescue analgesia when CHEOPS score was more than 3. Supplemental IV tramado, 1 mg/kg could be added if necessary every 6 hours.

Interventions

ultrasound anterior quadratum lumborum block with 1 ml/kg 0.2% ropivacaine

PROCEDUREcaudal block

ultrasound guided caudal block with 1 ml/kg 0.2% ropivacaine

Sponsors

Institut Kassab d'Orthopédie
CollaboratorOTHER
University Tunis El Manar
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
2 Years to 7 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 2 to 7 years old * Weight ≤ 20 Kg * American Society of Anesthesiologists (ASA) physical status I or II * Planned to undergo unilateral open hip reduction/osteotomies

Exclusion criteria

* Cerebral palsy with severe intellectual disability * Coagulation disorders * Local or general infection * Allergy to amide local anesthetics. * Progressive neurological disorders * Parenteral refusal * Spinal dysraphism * Cutaneous anomalies (angioma, hair truft, naevus or a dimple)near to the puncture

Design outcomes

Primary

MeasureTime frameDescription
analgesics consumptionday onetotal tramadol consumption

Secondary

MeasureTime frameDescription
postoperative pain scoreday oneChildren's Hospital Eastern Ontario Pain Scale (CHEOPS) \[4=no pain ; 13=worst pain\]
analgesic rescueDay onetime to first analgesic rescue

Countries

Tunisia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026